{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T15:58:46Z","timestamp":1783699126719,"version":"3.55.0"},"reference-count":36,"publisher":"The Japan Society of Coloproctology","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Anus Rectum Colon"],"published-print":{"date-parts":[[2025,1,25]]},"DOI":"10.23922\/jarc.2024-068","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T22:12:57Z","timestamp":1737756777000},"page":"105-116","source":"Crossref","is-referenced-by-count":2,"title":["The Impact of Hangeshashinto on Symptoms and Gut Microbiota in Diarrhea-type Irritable Bowel Syndrome: A Retrospective Analysis"],"prefix":"10.23922","volume":"9","author":[{"given":"Naohisa","family":"Yoshida","sequence":"first","affiliation":[{"name":"Department of Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Graduate School of Medical Science"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Yasuda","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Akashi City Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikazu","family":"Inagaki","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Nishijin Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Ayabe City Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Fukumoto","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Saiseikai Suita Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaaki","family":"Murakami","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Aiseikai Yamashina Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryohei","family":"Hirose","sequence":"additional","affiliation":[{"name":"Department of Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Graduate School of Medical Science"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Dohi","sequence":"additional","affiliation":[{"name":"Department of Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Graduate School of Medical Science"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Uchiyama","sequence":"additional","affiliation":[{"name":"Department of Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Graduate School of Medical Science"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohisa","family":"Takagi","sequence":"additional","affiliation":[{"name":"Department of Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Graduate School of Medical Science"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshito","family":"Itoh","sequence":"additional","affiliation":[{"name":"Department of Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Graduate School of Medical Science"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10009","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Palsson OS, Whitehead WE, van Tilburg MA, et al. Rome IV diagnostic questionnaires and tables for investigators and clinicians. Gastroenterology. 2016 May; 150 (6): 1481-91.","DOI":"10.1016\/S0016-5085(16)32508-2"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Lovell RM, Ford AC. Global prevalence of, and risk factors for, irritable bowel syndrome: A meta-analysis. Clin Gastroenterol Hepatol. 2012 Jul; 10 (7): 712-21.","DOI":"10.1016\/j.cgh.2012.02.029"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Fukudo S, Okumura T, Inamori M, et al. Evidence-based clinical practice guidelines for irritable bowel syndrome 2020. J Gastroenterol. 2021 Mar; 56 (3): 193-217.","DOI":"10.1007\/s00535-020-01746-z"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Enck P, Aziz Q, Barbara G, et al. Irritable bowel syndrome. Nat Rev Dis Primers. Mar 2016; 2: 16014.","DOI":"10.1038\/nrdp.2016.14"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Vivinus-Nebot M, Frin-Mathy G, Bzioueche H, et al. Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation. Gut. 2014 May; 63 (5): 744-52.","DOI":"10.1136\/gutjnl-2012-304066"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Barbara G, Grover M, Bercik P, et al. Rome Foundation working team report on post-infection irritable bowel syndrome. Gastroenterology. 2019 Jan; 156 (1): 46-58:e7.","DOI":"10.1053\/j.gastro.2018.07.011"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Pittayanon R, Lau JT, Yuan Y, et al. Gut microbiota in patients with irritable bowel syndrome - A systematic review. Gastroenterology. 2019 Jul; 157 (1): 97-108.","DOI":"10.1053\/j.gastro.2019.03.049"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Fritscher-Ravens A, Pflaum T, Mosinger M, et al. Many patients with irritable bowel syndrome have atypical food allergies not associated with immunoglobulin E. Gastroenterology. 2019 Jul; 157 (1): 109-18:e5.","DOI":"10.1053\/j.gastro.2019.03.046"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Ford AC, Harris LA, Lacy BE, Quigley EMM, Moayyedi P. Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome. Aliment Pharmacol Ther. 2018 Nov; 48 (10): 1044-60.","DOI":"10.1111\/apt.15001"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Zheng Y, Yu T, Tang Y, et al. Efficacy and safety of 5-hydroxytryptamine 3 receptor antagonists in irritable bowel syndrome: A systematic review and meta-analysis of randomized controlled trials. PLoS One. 2017 Mar; 12 (3): e0172846.","DOI":"10.1371\/journal.pone.0172846"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Yamazaki K, Ariyoshi N, Miyauchi H, et al. A randomized controlled, open-label early phase II trial comparing incidence of FOLFIRI.3-induced diarrhoea between Hangeshashinto and oral alkalization in Japanese patients with colorectal cancer. J Clin Pharm Ther. 2019 Dec; 44 (6): 946-51.","DOI":"10.1111\/jcpt.13020"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Takeuchi T, Hongo H, Kimura T, et al. Efficacy and safety of hangeshashinto for treatment of GERD refractory to proton pump inhibitors: Usual dose proton pump inhibitors plus hangeshashinto versus double-dose proton pump inhibitors: randomized, multicenter open label exploratory study. J Gastroenterol. 2019 Nov; 54 (11): 972-83.","DOI":"10.1007\/s00535-019-01588-4"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Matsuda C, Munemoto Y, Mishima H, et al. Double-blind, placebo-controlled, randomized phase II study of TJ-14 (Hangeshashinto) for infusional fluorinated-pyrimidine-based colorectal cancer chemotherapy-induced oral mucositis. Cancer Chemother Pharmacol. 2015 Jul; 76 (1): 97-103.","DOI":"10.1007\/s00280-015-2767-y"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Murai T, Matsuo M, Tanaka H, et al. Efficacy of herbal medicine TJ-14 for acute radiation-induced enteritis: a multi-institutional prospective Phase II trial. J Radiat Res. 2020 Jan; 61 (1): 140-5.","DOI":"10.1093\/jrr\/rrz025"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Kono T, Kaneko A, Matsumoto C, et al. Multitargeted effects of hangeshashinto for treatment of chemotherapy-induced oral mucositis on inducible prostaglandin E2 production in human oral keratinocytes. Integr Cancer Ther. 2014 Sep; 13 (5): 435-45.","DOI":"10.1177\/1534735413520035"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Fukamachi H, Matsumoto C, Omiya Y, et al. Effects of Hangeshashinto on Growth of Oral Microorganisms. Evid Based Complement Alternat Med. 2015; 2015: 512947.","DOI":"10.1155\/2015\/512947"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Hitomi S, Ono K, Yamaguchi K, et al. The traditional Japanese medicine hangeshashinto alleviates oral ulcer-induced pain in a rat model. Arch Oral Biol. 2016 Jun; 66: 30-7.","DOI":"10.1016\/j.archoralbio.2016.02.002"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Hitomi S, Ono K, Terawaki K, et al. [6]-gingerol and [6]-shogaol, active ingredients of the traditional Japanese medicine hangeshashinto, relief oral ulcerative mucositis-induced pain via action on Na<sup>+<\/sup> channels. Pharmacol Res. 2017 Mar; 117: 288-302.","DOI":"10.1016\/j.phrs.2016.12.026"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol. 1997 Sep; 32 (9): 920-4.","DOI":"10.3109\/00365529709011203"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Peduzzi P, Concato J, Kemper E, et al. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996 Dec; 49 (12): 1373-9.","DOI":"10.1016\/S0895-4356(96)00236-3"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Fujihara H, Matsunaga M, Ueda E, et al. Altered Gut Microbiota Composition Is Associated with Difficulty in Explicit Emotion Regulation in Young Children. Microorganisms. 2023 Sep; 11 (9): 2245.","DOI":"10.3390\/microorganisms11092245"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Nishimoto Y, Mizutani S, Nakajima T, et al. High stability of faecal microbiome composition in guanidine thiocyanate solution at room temperature and robustness during colonoscopy. Gut. 2016 Sep; 65 (9): 1574-5.","DOI":"10.1136\/gutjnl-2016-311937"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Kameoka S, Motooka D, Watanabe S, et al. Benchmark of 16S rRNA gene amplicon sequencing using Japanese gut microbiome data from the V1-V2 and V3-V4 primer sets. BMC Genomics. 2021 Jul; 22 (1): 527.","DOI":"10.1186\/s12864-021-07746-4"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. L\u00f3pez-Aladid R, Fern\u00e1ndez-Barat L, Alcaraz-Serrano V, et al. Determining the most accurate 16S rRNA hypervariable region for taxonomic identification from respiratory samples. Sci Rep. 2023 Mar; 13 (1): 3974.","DOI":"10.1038\/s41598-023-30764-z"},{"key":"25","unstructured":"25. Bolyen E, Rideout JR, Dillon MR, et al. Reproducible, Interactive, Scalable and Extensible Microbiome Data Science Using QIIME 2. Nat Biotechnol. 2019 Aug; 37 (8): 852-7."},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Bokulich NA, Dillon MR, Zhang Y, et al. q2-longitudinal: Longitudinal and Paired-Sample Analyses of Microbiome Data. mSystems. 2018 Nov; 3 (6): e00219-18.","DOI":"10.1128\/msystems.00219-18"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Mori K, Kondo T, Kamiyama Y, et al. Preventive effect of kampo medicine (Hangeshashin-to) against irinotecan-induced diarrhea in advanced non-small-cell lung cancer. Cancer Chemother Pharmacol. 2003; 51 (5): 403-6.","DOI":"10.1007\/s00280-003-0585-0"},{"key":"28","unstructured":"28. Tana C, Umesaki Y, Imaoka A, Handa T, Kanazawa M, Fukudo S. Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome. Neurogastroenterol Motil. 2010 May; 22 (5): 512-9,e114-5."},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Brown CT, Davis-Richardson AG, Giongo A, et al. Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes. PLoS One. 2011; 6 (10): e25792.","DOI":"10.1371\/journal.pone.0025792"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Carco C, Young W, Gearry RB, et al. Increasing Evidence That Irritable Bowel Syndrome and Functional Gastrointestinal Disorders Have a Microbial Pathogenesis. Front Cell Infect Microbiol. 2020 Sep; 10: 468.","DOI":"10.3389\/fcimb.2020.00468"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Malinen E, Rinttila T, Kajander K, et al. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol. 2005 Feb; 100 (2): 373-82.","DOI":"10.1111\/j.1572-0241.2005.40312.x"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Lyra A, Rinttila T, Nikkila J, et al. Diarrhoea-predominant irritable bowel syndrome distinguishable by 16S rRNA gene phylotype quantification. World J Gastroenterol. 2009 Dec; 15 (47): 5936-45.","DOI":"10.3748\/wjg.15.5936"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Walsh J, Griffin BT, Clarke G, et al. Drug-gut microbiota interactions: implications for neuropharmacology. Br J Pharmacol. 2018 Dec; 175 (24): 4415-29.","DOI":"10.1111\/bph.14366"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Nagata N, Nishijima S, Miyoshi-Akiyama T, et al. Population-level Metagenomics Uncovers Distinct Effects of Multiple Medications on the Human Gut Microbiome. Gastroenterology. 2022 Oct; 163 (4): 1038-52.","DOI":"10.1053\/j.gastro.2022.06.070"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Slattery SA, Niaz O, Aziz Q, et al. Systematic review with metaanalysis: the prevalence of bile acid malabsorption in the irritable bowel syndrome with diarrhoea. Aliment Pharmacol Ther. 2015 Jul; 42 (1): 3-11.","DOI":"10.1111\/apt.13227"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Vijayvargiya P, Busciglio I, Burton D, et al. Bile acid deficiency in a subgroup of patients with irritable bowel syndrome with constipation based on biomarkers in serum and fecal samples. Clin Gastroenterol Hepatol. 2018 Apr; 16 (4): 522-7.","DOI":"10.1016\/j.cgh.2017.06.039"}],"container-title":["Journal of the Anus, Rectum and Colon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jarc\/9\/1\/9_2024-068\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T04:54:59Z","timestamp":1737780899000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jarc\/9\/1\/9_2024-068\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,25]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.23922\/jarc.2024-068","relation":{},"ISSN":["2432-3853"],"issn-type":[{"value":"2432-3853","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,25]]},"article-number":"2024-068"}}